Molecularly targeted immunotherapy used to treat a novel overlap syndrome of pediatric N‐methyl‐ d‐aspartate receptor encephalitis (NMDARE) and possible neurosarcoidosis

• Hauptverfasser: Elizabeth Pickup (Verfasst von), Christopher Redmond (Verfasst von), Matthew A. Sherman (Verfasst von), Lakshmi Ramachandran Nair (Verfasst von), Sangeeta Sule (Verfasst von), Elizabeth Wells (Verfasst von), Alexandra B. Kornbluh (Verfasst von)
• Format: Buch
• Veröffentlicht: Wiley, 2024-06-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Objective Overlap syndromes have been described between N‐methyl‐ d‐aspartate receptor encephalitis (NMDARE) and other neuroinflammatory conditions, although rarely involving neurosarcoidosis. Molecularly targeted immunotherapy may be helpful in the empiric treatment of these conditions. Me...